| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/28/2012 | US8124765 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine |
| 02/28/2012 | US8124647 Non-steroidal androgens compounds |
| 02/28/2012 | US8124628 Diaryl substituted alkanes |
| 02/28/2012 | US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives |
| 02/28/2012 | US8124605 Compositions and methods for modulating a kinase cascade |
| 02/28/2012 | US8124604 Inhibitors of bruton's tyrosine kinase |
| 02/28/2012 | CA2514220C Ep4 receptor antagonists |
| 02/23/2012 | WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 02/23/2012 | WO2012024363A2 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 02/23/2012 | WO2012024150A1 Oxadiazole inhibitors of leukotriene production |
| 02/23/2012 | WO2012023487A1 Metal complex, fluorescent probe |
| 02/23/2012 | WO2012022776A1 Substituted thiopenes or furans as estrogen receptor ligands |
| 02/23/2012 | WO2012022408A1 Pyrimidine derivatives as fak inhibitors |
| 02/23/2012 | WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof |
| 02/23/2012 | WO2012003405A4 Sgc stimulators |
| 02/23/2012 | WO2011143425A3 Compounds useful as inhibitors of atr kinase |
| 02/23/2012 | WO2011119894A3 Heterocyclic compounds useful for kinase inhibition |
| 02/23/2012 | US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 02/23/2012 | US20120046289 Pyridazine Carboxamide Orexin Receptor Antagonists |
| 02/23/2012 | US20120046288 Hydrazonamide Compounds That Modulate Hsp90 Activity |
| 02/23/2012 | US20120046286 Novel Compounds |
| 02/23/2012 | US20120046285 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
| 02/23/2012 | US20120046284 Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-methoxy-quinazoline, their use as a medicament and the preparation thereof |
| 02/23/2012 | US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors |
| 02/23/2012 | US20120046277 Benzofuran derivatives |
| 02/23/2012 | US20120046273 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| 02/23/2012 | US20120046269 Novel Amino Azaheterocyclic Carboxamides |
| 02/23/2012 | US20120046268 Substituted piperidines as Par-1 Antagonists |
| 02/23/2012 | US20120046266 Resorcinol derivatives as hsp90 inhibitors |
| 02/23/2012 | US20120046245 Compositions and methods for inhibition of the jak pathway |
| 02/23/2012 | US20120045509 Modified release compositions for dpp-iv inhibitors |
| 02/23/2012 | US20120045454 2,4-pyrimidinediamine compounds and their uses |
| 02/23/2012 | CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 02/23/2012 | CA2808543A1 Pyrrolopyrimidine compounds and uses thereof |
| 02/23/2012 | CA2808540A1 Pyrimidine derivatives as fak inhibitors |
| 02/23/2012 | CA2808291A1 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 02/23/2012 | CA2807364A1 Oxadiazole inhibitors of leukotriene production |
| 02/22/2012 | EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
| 02/22/2012 | EP2420491A1 3 , 5-substitued piperidine compounds as renin inhibitors |
| 02/22/2012 | EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease |
| 02/22/2012 | EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2419411A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders |
| 02/22/2012 | EP2419405A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds |
| 02/22/2012 | EP2419404A1 Anti-viral compounds |
| 02/22/2012 | EP2245028B1 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1937666B1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 02/22/2012 | EP1644363B1 Triheterocyclic compounds, compositions, and methods for treating cancer |
| 02/22/2012 | CN102361869A Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 02/22/2012 | CN102361868A Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists |
| 02/22/2012 | CN102361867A Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 02/22/2012 | CN102361866A Process for the preparation of propionic acid derivatives |
| 02/22/2012 | CN102361863A Novel bicyclic antibiotics |
| 02/22/2012 | CN102361862A Thiophenyl sulfonamides for the treatment of alzheimer's disease |
| 02/22/2012 | CN102361859A Heteroaryl compounds useful as Raf kinase inhibitors |
| 02/22/2012 | CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 02/22/2012 | CN102358738A 2,4-pyrimidinediamine compounds and uses of treating or preventing autoimmune diseases thereof |
| 02/22/2012 | CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119808 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 02/21/2012 | US8119797 Production method |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119680 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom |
| 02/21/2012 | US8119678 Compounds, compositions and methods |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 02/21/2012 | US8119633 Substituted sulfonamide compounds |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119630 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 02/21/2012 | US8119626 Oxime derivative and preparations thereof |
| 02/21/2012 | US8119624 Fused phenyl amido heterocyclic compounds |
| 02/21/2012 | US8119623 Pyrrolidin-2-ones |
| 02/21/2012 | CA2663984C Biaryl ether urea compounds |
| 02/21/2012 | CA2515727C Process for the preparation of bicyclic aromatic amino acids and intermediates thereof |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/16/2012 | WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 02/16/2012 | WO2012021712A1 Tetracycline analogs |
| 02/16/2012 | WO2012021591A1 Hepatitis c virus inhibitors |
| 02/16/2012 | WO2012020820A1 Heteroaryl-pyrazole derivative |
| 02/16/2012 | WO2012020813A1 Fused-ring pyrrolidine derivative |
| 02/16/2012 | WO2012020787A1 Malignant lymphoma therapeutic agent |
| 02/16/2012 | WO2012020786A1 Pharmaceutical composition |
| 02/16/2012 | WO2012020762A1 Hetero ring compound |
| 02/16/2012 | WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 02/16/2012 | WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε |
| 02/16/2012 | WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism |
| 02/16/2012 | WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers |
| 02/16/2012 | WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 02/16/2012 | WO2012019862A1 Process for making linezolid |
| 02/16/2012 | WO2012019632A1 Process for making linezolid |
| 02/16/2012 | US20120041026 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
| 02/16/2012 | US20120041009 Pyrimidine compound and its use in pest control |
| 02/16/2012 | US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/16/2012 | US20120040998 2-alkyl piperidine mglur5 receptor modulators |
| 02/16/2012 | US20120040991 3-azabicyclo [4.1.0] heptanes used as orexin antagonists |
| 02/16/2012 | US20120040986 Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/16/2012 | US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity |
| 02/16/2012 | US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof |